Early research

P21

P21 (CNTF-derived peptide)

AI explanation

P21: The Cognitive Enhancement Peptide

P21 is a synthetic peptide—essentially a short chain of amino acids—that researchers designed based on a natural protein your brain already uses called CNTF. People are interested in it because early research suggests it can sharpen your memory, help you recognize patterns better, and generally boost how well your brain works. Think of it as a key that unlocks your brain's potential to grow new neurons, particularly in the hippocampus, the area responsible for forming memories.

Here's how it actually works: your brain naturally produces new nerve cells throughout your life, but this process slows down. P21 essentially sends a signal to your neural stem cells—your brain's blank slate cells—telling them to wake up and multiply. It does this by activating specific receptors on these cells, which then triggers a chain reaction of signals inside the cell. These signals tell the stem cells to divide and transform into actual working neurons. P21 also pumps up production of a growth factor called BDNF that helps these new neurons survive and wire themselves into your existing brain circuits. The result is more functional neurons in your memory center, which translates to better recall and mental flexibility. It's like giving your brain's natural growth system a powerful amplifier.

Dosage Information

Typical Dose

100-300 mcg daily

Frequency

Once daily

Anytime

Administration

Subcutaneous injection

Half-Life

~2 hours

estimated

Notes

Limited human data available. Often stacked with Cerebrolysin in research protocols. Cycles of 4-8 weeks typically used.

Why this matters

BDNF-enhancing peptide; subcutaneous injection in research settings.

Protocol cycle

4-8 weeks· Typical research protocol cycle duration

Dose Calculator

Calculate your draw amount for an insulin syringe (U-100)

Concentration: 2,500 mcg/mL

Sign in to save your reconstitution settings for this peptide

Draw to the

4

unit mark

020406080100

Draw 4 units for your 100mcg dose of P21

This calculator is for educational purposes. Always verify your calculations and consult a healthcare professional.

Where does P21 sit?

See how this peptide compares across all 150 peptides in our database.

Evidence Score

0.07

Clinical trials
0.0035%
Literature
0.0030%
Community
0.0020%
Completeness
0.5015%

Potential Side Effects

Limited human safety dataVivid dreams reported anecdotally (common in community reports)Mild headache (uncommon)Fatigue in first week (uncommon)
Pep Talk

P21 discussions

Quick Facts

Administration
Subcutaneous injection
Typical Dose
100-300 mcg daily
Frequency
Once daily
References
0 curated + 0 from PubMed
Evidence Score
0.1 / 100

Frequently Asked Questions about P21

What is P21?

P21 is a synthetic peptide derived from the ciliary neurotrophic factor (CNTF) binding interface that has demonstrated potent neurogenic and cognitive enhancement properties in preclinical research. It is one of the most discussed emerging nootropic peptides in the research community due to reports of dramatic improvements in memory pattern recognition and cognitive function. P21 promotes neurogenesis in the hippocampus and has shown synergistic effects with Cerebrolysin in animal models. While human trial data is limited this peptide represents the frontier of neurogenic peptide research.

How does P21 work?

P21 acts by modulating the CNTF signaling pathway specifically targeting the gp130 and LIFRβ receptor complex that mediates CNTF's neurotrophic effects. By binding to the CNTF receptor interface P21 activates JAK-STAT signaling in neural stem cells promoting their proliferation and differentiation into neurons particularly in the hippocampal dentate gyrus — the primary site of adult neurogenesis. P21 also upregulates BDNF expression and reduces the activity of inhibitory factors that suppress neural stem cell division. The result is enhanced hippocampal neurogenesis which correlates with improvements in spatial memory pattern separation and cognitive flexibility in animal models. P21 appears to have a particularly strong effect on new neuron survival and integration into existing neural circuits.

What is the recommended dosage for P21?

The typical dose is 100-300 mcg daily. Once daily. Administration: Subcutaneous injection. Limited human data available. Often stacked with Cerebrolysin in research protocols. Cycles of 4-8 weeks typically used.

What are the side effects of P21?

Limited human safety data. Vivid dreams reported anecdotally (common in community reports). Mild headache (uncommon). Fatigue in first week (uncommon)

What is the P21 cycle protocol?

P21 is typically cycled 4-8 weeks. Typical research protocol cycle duration

Questions reflect common community inquiries. This is not medical advice.